Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy. - Zhang, Ruijing; Chang, Runze; Wang, Heng; Chen, Jinshan; Lu, Chuanlong; Fan, Keyi; Zhang, Yuhang; Li, Lizheng; Yan, Sheng; Dong, Honglin (Scientific Reports, 2025)